Changes in medical management and colectomy rates: a population ‐based cohort study on the epidemiology and natural history of ulcerative colitis in Örebro, Sweden, 1963‐2010
Summary BackgroundWhether the epidemiology of ulcerative colitis (UC) has changed during recent decades is partly unknown. AimTo depict temporal trends in the epidemiology and medical treatment of UC as well as the long‐term risk of progression in disease extent and colectomy, during 1963‐2010. MethodsPatients were identified by evaluation of all medical records in the archive of the Colitis Clinic, Örebro University Hospital. Comparisons were made between three time periods, 1963‐1975, 1976‐1990 and 1991‐2005. ResultsThe annual age‐standardised incidence increased from 3.5 to 18.5 per 100 000 during the study period (P
Source: Alimentary Pharmacology and Therapeutics - August 18, 2017 Category: Drugs & Pharmacology Authors: C. Eriksson, Y. Cao, S. Rundquist, Y. Zhulina, I. Henriksson, S. Montgomery, J. Halfvarson Tags: ORIGINAL ARTICLE Source Type: research

Lenalidomide as second ‐line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy
Abstract BackgroundLenalidomide has immunomodulatory and anti‐angiogenic effects and showed moderate anti‐tumour efficacy in patients with. advanced hepatocellular carcinoma (HCC) AimTo explore potential biomarkers of lenalidomide efficacy as second‐line therapy for HCC. MethodsEligible patients were diagnosed with advanced HCC, documented progression on sorafenib, and Child‐Pugh class A liver function. Patients received 25 mg/day lenalidomide orally on days 1‐21 every 4 weeks. The primary endpoint was 6 month progression‐free survival rate. Early α‐fetoprotein response was defined as a> 20% decline ...
Source: Alimentary Pharmacology and Therapeutics - August 17, 2017 Category: Drugs & Pharmacology Authors: Y. ‐Y. Shao, B.‐B. Chen, D.‐L. Ou, Z.‐Z. Lin, C.‐H. Hsu, M.‐J. Wang, A.‐L. Cheng, C. Hsu Tags: ORIGINAL ARTICLE Source Type: research

Systematic review with meta ‐analysis: enteral nutrition therapy for the induction of remission in paediatric Crohn's disease
ConclusionsThere is no difference in efficacy between Exclusive enteral nutrition and corticosteroids in induction of remission in Crohn's disease in a paediatric population. Exploratory analyses suggest that a greater proportion of patients treated with exclusive enteral nutrition achieved mucosal healing. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 16, 2017 Category: Drugs & Pharmacology Authors: A. Swaminath, A. Feathers, A. N. Ananthakrishnan, L. Falzon, S. Li Ferry Tags: SYSTEMATIC REVIEW WITH META ‐ANALYSIS Source Type: research

Impact of beta ‐blockers on cardiopulmonary exercise testing in patients with advanced liver disease
Summary BackgroundPatients with advanced liver disease may develop portal hypertension that can result in variceal haemorrhage. Beta‐blockers reduce portal pressure and minimise haemorrhage risk. These medications may attenuate measures of cardiopulmonary performance, such as the ventilatory threshold and peak oxygen uptake measured via cardiopulmonary exercise testing. AimTo determine the effect of beta‐blockers on cardiopulmonary exercise testing variables in patients with advanced liver disease. MethodsThis was a cross‐sectional analysis of 72 participants who completed a cardiopulmonary exercise test before liver...
Source: Alimentary Pharmacology and Therapeutics - August 14, 2017 Category: Drugs & Pharmacology Authors: M. P. Wallen, A. Hall, K. A. Dias, J. S. Ramos, S. E. Keating, A. J. Woodward, T. L. Skinner, G. A. Macdonald, R. Arena, J. S. Coombes Tags: ORIGINAL ARTICLE Source Type: research

Letter: inconsistency in reporting of hypophosphataemia after intravenous iron —authors’ reply
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 14, 2017 Category: Drugs & Pharmacology Authors: A. Aksan, H. I şık, H. H. Radeke, A. Dignass, J. Stein Tags: LETTER TO THE EDITOR Source Type: research

Letter: inconsistency in reporting of hypophosphatemia after intravenous iron
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 14, 2017 Category: Drugs & Pharmacology Authors: B. Schaefer, B. Glodny, M. Wolf, H. Zoller Tags: LETTER TO THE EDITOR Source Type: research

Letter: complex interplay between obesity and Clostridium difficile infection —authors’ reply
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 14, 2017 Category: Drugs & Pharmacology Authors: R. Mulki, P. Katz Tags: LETTER TO THE EDITOR Source Type: research

Letter: complex interplay between obesity and Clostridium difficile infection
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 14, 2017 Category: Drugs & Pharmacology Authors: A. Kapur, V. Nagaraja Tags: LETTER TO THE EDITOR Source Type: research

Letter: the treatment of coronary artery disease in cirrhotics needs more thinking —author's reply
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 14, 2017 Category: Drugs & Pharmacology Authors: L. A. Feagins Tags: LETTER TO THE EDITOR Source Type: research

Letter: the treatment of coronary artery disease in cirrhotics needs more thinking
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 14, 2017 Category: Drugs & Pharmacology Authors: J. Zhao, H. Tian, C. Liang Tags: LETTER TO THE EDITOR Source Type: research

Letter: Helicobacter pylori in lean and obese patients with non ‐alcoholic fatty liver disease
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 14, 2017 Category: Drugs & Pharmacology Authors: J. Kountouras, S. A. Polyzos, P. Katsinelos, M. Doulberis, C. Zavos, E. Kazakos, M. Boziki, D. Tzivras, G. Kotronis Tags: LETTER TO THE EDITOR Source Type: research

Letter: the definition of budesonide dependence in microscopic colitis —authors’ reply
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 14, 2017 Category: Drugs & Pharmacology Authors: T. G. Cotter, A. K. Kamboj, S. B. Hicks, W. J. Tremaine, E. V. Loftus Jr, D. S. Pardi Tags: LETTER TO THE EDITOR Source Type: research

Letter: the definition of budesonide dependence in microscopic colitis
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 14, 2017 Category: Drugs & Pharmacology Authors: F. Fern ández‐Bañares, J. P. Gisbert Tags: LETTER TO THE EDITOR Source Type: research

Editorial: probiotics in inflammatory bowel disease —wrong organisms, wrong disease, or flawed concepts? Authors’ reply
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 14, 2017 Category: Drugs & Pharmacology Authors: D. J. Gracie, Y. Derwa, P. J. Hamlin, A. C. Ford Tags: INVITED EDITORIAL Source Type: research

Editorial: probiotics in inflammatory bowel disease —wrong organisms, wrong disease, or flawed concepts?
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 14, 2017 Category: Drugs & Pharmacology Authors: F. Shanahan Tags: INVITED EDITORIAL Source Type: research

Editorial: faecal microbiota transplantation for ulcerative colitis —not quite there yet? Authors’ reply
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 14, 2017 Category: Drugs & Pharmacology Authors: S. P. Costello, W. Soo, R. V. Bryant, V. Jairath, A. L. Hart, J. M. Andrews Tags: INVITED EDITORIAL Source Type: research

Editorial: faecal microbiota transplantation for ulcerative colitis —not quite there yet?
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 14, 2017 Category: Drugs & Pharmacology Authors: M. H. Lim, G. L. Radford ‐Smith Tags: INVITED EDITORIAL Source Type: research

Editorial: good news to patients with thalassaemia —HCV clearance made easy with direct acting antivirals. Authors’ reply
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 14, 2017 Category: Drugs & Pharmacology Authors: A. Mangia, V. Piazzolla, R. Santoro Tags: INVITED EDITORIAL Source Type: research

Editorial: good news to patients with thalassaemia —HCV clearance made easy with direct‐acting antivirals
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 14, 2017 Category: Drugs & Pharmacology Authors: R. D'Ambrosio, P. Lampertico Tags: INVITED EDITORIAL Source Type: research

Safety of herpes zoster vaccination among inflammatory bowel disease patients being treated with anti ‐TNF medications
ConclusionOur data suggest that co‐administering the herpes zoster vaccine to patients who are taking anti‐TNF medications is relatively safe. This study significantly expands the evidence supporting the use of herpes zoster vaccine in this population, having included an elderly group of patients with a high Charlson Comorbidity Index who are likely at a much higher risk of developing HZ. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 14, 2017 Category: Drugs & Pharmacology Authors: N. Khan, Y. Shah, C. Trivedi, J. D. Lewis Tags: ORIGINAL ARTICLE Source Type: research

Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection
ConclusionsIn a retrospective analysis of patients who underwent endoscopic resection of EGCs, eradication of H. pylori infection reduced risk for metachronous gastric neoplasm. Serum ratio of PGI:PGII of 3 or less also increase risk of metachronous gastric neoplasm after endoscopic submucosal dissection. ClinicalTrials.gov. registry number, NCT02682446. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 11, 2017 Category: Drugs & Pharmacology Authors: Y. Kwon, S. Jeon, S. Nam, I. Shin Tags: ORIGINAL ARTICLE Source Type: research

Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct ‐acting antivirals? A prospective multicentre study
ConclusionsProbability of HCC early recurrence in patients who had HCC previously cured remains high, despite HCV eradication by DAAs. Risk was comparable but not higher to that reported in literature in DAA‐untreated patients. Previous HCC recurrence and tumour size can be used to stratify the risk of HCC early recurrence. Further studies are needed to assess impact of DAAs on late recurrence and mortality. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 9, 2017 Category: Drugs & Pharmacology Authors: G. Cabibbo, S. Petta, V. Calvaruso, I. Cacciola, M. R. Cannav ò, S. Madonia, M. Distefano, L. Larocca, T. Prestileo, F. Tinè, G. Bertino, L. Giannitrapani, F. Benanti, A. Licata, I. Scalisi, G. Mazzola, F. Cartabellotta, N. Alessi, M. Barbàra, M. Russe Tags: ORIGINAL ARTICLE Source Type: research

Undetectable negative tissue transglutaminase IgA antibodies predict mucosal healing in treated coeliac disease patients
Summary BackgroundTissue transglutaminase (tTG) immunoglobulin A (IgA) testing is a sensitive adjunct to the diagnosis of coeliac disease. The threshold for positivity was developed for diagnosis, with negative results reported as below the reference value (
Source: Alimentary Pharmacology and Therapeutics - August 7, 2017 Category: Drugs & Pharmacology Authors: H. Fang, K. S. King, J. J. Larson, M. R. Snyder, T. T Wu, M. J. Gandhi, J. A. Murray Tags: ORIGINAL ARTICLE Source Type: research

Systematic review with meta ‐analysis: diagnostic performance of the combination of pepsinogen, gastrin‐17 and anti‐Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis
ConclusionsThe combination of pepsinogen, gastrin‐17 and anti‐H. pylori antibodies serological assays appears to be a reliable tool for the diagnosis of atrophic gastritis. This test may be used for screening subjects or populations at high risk of gastric cancer for atrophic gastritis; however, a cost‐effectiveness analysis is needed. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 7, 2017 Category: Drugs & Pharmacology Authors: R. M. Zagari, S. Rabitti, D. C. Greenwood, L. H. Eusebi, A. Vestito, F. Bazzoli Tags: SYSTEMATIC REVIEW WITH META ‐ANALYSIS Source Type: research

Letter: non ‐alcoholic fatty liver disease and polycystic ovary syndrome—evidence for low vitamin D status contributing to the link
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 4, 2017 Category: Drugs & Pharmacology Authors: Q. Pang, L. Zhou, H. Jin, Z. R. Man, H. C. Liu Tags: LETTER TO THE EDITOR Source Type: research

Letter: a potassium ‐competitive acid blocker vs a proton pump inhibitor for healing endoscopic submucosal dissection‐induced artificial ulcers after treatment of gastric neoplasms—authors’ reply
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 4, 2017 Category: Drugs & Pharmacology Authors: T. Kagawa, M. Iwamuro, T. Inaba Tags: LETTER TO THE EDITOR Source Type: research

Letter: a potassium ‐competitive acid blocker vs a proton pump inhibitor for healing endoscopic submucosal dissection‐induced artificial ulcers after treatment of gastric neoplasms
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 4, 2017 Category: Drugs & Pharmacology Authors: H. Ban, M. Sugimoto, T. Otsuka, M. Murata, T. Nakata, H. Hasegawa, M. Fukuda, O. Inatomi, S. Bamba, R. Kushima, A. Andoh Tags: LETTER TO THE EDITOR Source Type: research

Letter: role of tenofovir to prevent mother ‐to‐child transmission of hepatitis B virus—authors’ reply
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 4, 2017 Category: Drugs & Pharmacology Authors: Y. ‐S. Lee, M. H. Hyun, J. H. Kim, J. E. Yeon, K. S. Byun Tags: LETTER TO THE EDITOR Source Type: research

Letter: role of tenofovir to prevent mother ‐to‐child transmission of hepatitis B virus
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 4, 2017 Category: Drugs & Pharmacology Authors: C. ‐Y. Zhang, B.‐K. Ahir, G‐B. Wu, J.‐H. Zhong, L.‐Q. Li Tags: LETTER TO THE EDITOR Source Type: research

Editorial: progress towards a simple tool for screening for hepatic steatosis in the general population – authors’ reply
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 4, 2017 Category: Drugs & Pharmacology Authors: T. C. ‐F. Yip, A. J. Ma, P.‐C. Yuen, G. L.‐H. Wong Tags: INVITED EDITORIAL Source Type: research

Editorial: progress towards a simple tool for screening for hepatic steatosis in the general population
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 4, 2017 Category: Drugs & Pharmacology Authors: J. Gallacher, S. McPherson Tags: INVITED EDITORIAL Source Type: research

Editorial: oesophageal dilation in eosinophilic oesophagitis —can and should, but when and how? Authors’ reply
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 4, 2017 Category: Drugs & Pharmacology Authors: F. J. Moawad, A. J. Lucendo, J. Molina ‐Infante Tags: INVITED EDITORIAL Source Type: research

Editorial: oesophageal dilation in eosinophilic oesophagitis —can and should, but when and how?
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 4, 2017 Category: Drugs & Pharmacology Authors: L. Kia, I. Hirano Tags: INVITED EDITORIAL Source Type: research

Editorial: how effective is vedolizumab in the ‘real world’?
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 4, 2017 Category: Drugs & Pharmacology Authors: R. A. Speight, J. C. Mansfield Tags: INVITED EDITORIAL Source Type: research

Editorial: depression in the setting of inflammatory bowel disease means we have failed to provide early, effective, psychosocial care —authors’ reply
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 4, 2017 Category: Drugs & Pharmacology Authors: C. Alexakis, S. Kumar, S. Saxena, M. Hotopf, R. Pollok Tags: INVITED EDITORIAL Source Type: research

Editorial: depression in the setting of inflammatory bowel disease means we have failed to provide early, effective, psychosocial care
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 4, 2017 Category: Drugs & Pharmacology Authors: L. Keefer Tags: INVITED EDITORIAL Source Type: research

Editorial: selective serotonin receptor inhibitors and gastrointestinal bleeding —managing the risk
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 4, 2017 Category: Drugs & Pharmacology Authors: Nimish Vakil Tags: INVITED EDITORIAL Source Type: research

Editorial: replacing standard proton pump inhibitors with vonoprazan may breathe new life into triple therapy for Helicobacter pylori —authors’ reply
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 4, 2017 Category: Drugs & Pharmacology Authors: Y. S. Jung, E. H. Kim, C. H. Park Tags: INVITED EDITORIAL Source Type: research

Editorial: replacing standard proton pump inhibitors with vonoprazan may breathe new life into triple therapy for Helicobacter pylori
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 4, 2017 Category: Drugs & Pharmacology Authors: A. G. Fraser Tags: INVITED EDITORIAL Source Type: research

Editorial: lean and obese NAFLD —similar siblings
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 4, 2017 Category: Drugs & Pharmacology Authors: T. E. Mellor, D. M. Torres Tags: INVITED EDITORIAL Source Type: research

Ethnic disparities in progression to advanced liver disease and overall survival in patients with chronic hepatitis C: impact of a sustained virological response
ConclusionHispanic and Asian ethnicity was independently associated with increased cirrhosis and HCC risk. Achieving an SVR eliminates the ethnic disparity in liver disease progression and overall survival between Hispanic and Asian vs Caucasian CHC patients. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - August 1, 2017 Category: Drugs & Pharmacology Authors: A. K. Le, C. Zhao, J. K. Hoang, S. A. Tran, C. Y. Chang, M. Jin, N. H. Nguyen, L. A. Yasukawa, J. Q. Zhang, S. C. Weber, G. Garcia, M. H. Nguyen Tags: ORIGINAL ARTICLE Source Type: research

Anti ‐TNF treatment in Crohn's disease and risk of bowel resection—a population based cohort study
SUMMARY BackgroundTNF inhibitors (TNFi) have been shown to reduce the need for surgery in Crohn's disease, but few studies have examined their effect beyond the first year of treatment. AimTo conduct a register‐based observational cohort study in Sweden 2006‐2014 to investigate the risk of bowel resection in bowel surgery naïve TNFi‐treated Crohn's disease patients and whether patients on TNFi ≥12 months are less likely to undergo bowel resection than patients discontinuing treatment before 12 months. MethodsWe identified all individuals in Sweden with Crohn's disease through the Swedish National Patient Regi...
Source: Alimentary Pharmacology and Therapeutics - July 28, 2017 Category: Drugs & Pharmacology Authors: M. Eberhardson, J. K. S öderling, M. Neovius, T. Cars, P. Myrelid, J. F. Ludvigsson, J. Askling, A. Ekbom, O. Olén Tags: ORIGINAL ARTICLE Source Type: research

Serial combination of non ‐invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD
Summary BackgroundThe accuracy of available non‐invasive tools for staging severe fibrosis in patients with nonalcoholic fatty liver disease (NAFLD) is still limited. AimTo assess the diagnostic performance of paired or serial combination of non‐invasive tools in NAFLD patients. MethodsWe analysed data from 741 patients with a histological diagnosis of NAFLD. The GGT/PLT, APRI, AST/ALT, BARD, FIB‐4, and NAFLD Fibrosis Score (NFS) scores were calculated according to published algorithms. Liver stiffness measurement (LSM) was performed by FibroScan. ResultsLSM, NFS and FIB‐4 were the best non‐invasive tools for sta...
Source: Alimentary Pharmacology and Therapeutics - July 28, 2017 Category: Drugs & Pharmacology Authors: S. Petta, V. W. ‐S. Wong, C. Cammà, J.‐B. Hiriart, G. L.‐H. Wong, J. Vergniol, A. W.‐H. Chan, V. Di Marco, W. Merrouche, H. L.‐Y. Chan, F. Marra, B. Le‐Bail, U. Arena, A. Craxì, V. Ledinghen Tags: ORIGINAL ARTICLE Source Type: research

Review article: the many potential roles of intestinal serotonin (5 ‐hydroxytryptamine, 5‐HT) signalling in inflammatory bowel disease
ConclusionsInsights discussed in this review have strong potential to lead to new diagnostic and therapeutic tools to improve the management of IBD and other related disorders. Specifically, strategies that focus on modifying the activity of selective serotonin receptors and reuptake transporters in the gut could be effective for controlling disease activity and/or its associated symptoms. Further studies in humans are required, however, to more completely understand the pathophysiological mechanisms underlying the roles of 5‐HT in this setting. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - July 24, 2017 Category: Drugs & Pharmacology Authors: M. D. Coates, I. Tekin, K. E. Vrana, G. M. Mawe Tags: REVIEW ARTICLE Source Type: research

Systematic review with meta ‐analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection
ConclusionFaecal microbiota transplantation is an effective treatment for recurrent and refractory Clostridium difficile infection, independent of preparation and route of delivery. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - July 14, 2017 Category: Drugs & Pharmacology Authors: M. N. Quraishi, M. Widlak, N. Bhala, D. Moore, M. Price, N. Sharma, T. H. Iqbal Tags: SYSTEMATIC REVIEW WITH META ‐ANALYSIS Source Type: research

Letter: liver transplantation for acute HEV infection in cirrhotic patients in France
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - July 14, 2017 Category: Drugs & Pharmacology Authors: P. Borentain, P. Colson, E. Gregoire, G. Allard, R. Gerolami Tags: LETTER TO THE EDITOR Source Type: research

Letter: direct ‐acting agent therapy and HCV‐related Child C cirrhosis
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - July 14, 2017 Category: Drugs & Pharmacology Authors: A. Braillon Tags: LETTER TO THE EDITOR Source Type: research

Letter: there is something about the Neutrophil ‐to‐Lymphocyte ratio (NLR)…—authors' reply
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - July 14, 2017 Category: Drugs & Pharmacology Authors: Y. ‐J. Cai, K.‐Q. Shi, M.‐T. Zhou Tags: LETTER TO THE EDITOR Source Type: research

Letter: there's something about the Neutrophil ‐to‐Lymphocyte ratio (NLR)…
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - July 14, 2017 Category: Drugs & Pharmacology Authors: E. H. Forrest Tags: LETTER TO THE EDITOR Source Type: research

Letter: sprue ‐like enteropathy associated with angiotensin II receptor blockers other than olmesartan—authors'reply
(Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - July 14, 2017 Category: Drugs & Pharmacology Authors: L. Marthey, F. Carbonnel Tags: LETTER TO THE EDITOR Source Type: research